<div class="container">

<table style="width: 100%;"><tr>
<td>GBSG2</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>German Breast Cancer Study Group 2</h2>

<h3>Description</h3>

<p>A data frame containing the observations from the GBSG2 study.
</p>


<h3>Format</h3>

<p>This data frame contains the observations of 686 women: </p>

<dl>
<dt>horTh</dt>
<dd>
<p>hormonal therapy, a factor at two levels <code>no</code> and
<code>yes</code>.</p>
</dd> <dt>age</dt>
<dd>
<p>of the patients in years.</p>
</dd>
<dt>menostat</dt>
<dd>
<p>menopausal status, a factor at two levels <code>pre</code>
(premenopausal) and <code>post</code> (postmenopausal).</p>
</dd> <dt>tsize</dt>
<dd>
<p>tumor size
(in mm).</p>
</dd> <dt>tgrade</dt>
<dd>
<p>tumor grade, a ordered factor at levels <code>I &lt; II
&lt; III</code>.</p>
</dd> <dt>pnodes</dt>
<dd>
<p>number of positive nodes.</p>
</dd>
<dt>progrec</dt>
<dd>
<p>progesterone receptor (in fmol).</p>
</dd> <dt>estrec</dt>
<dd>
<p>estrogen
receptor (in fmol).</p>
</dd> <dt>time</dt>
<dd>
<p>recurrence free survival time (in days).</p>
</dd>
<dt>cens</dt>
<dd>
<p>censoring indicator (0- censored, 1- event).</p>
</dd> </dl>
<h3>References</h3>

<p>M. Schumacher, G. Basert, H. Bojar, K. Huebner, M. Olschewski,
W. Sauerbrei, C. Schmoor, C. Beyerle, R.L.A. Neumann and H.F. Rauschecker
for the German Breast Cancer Study Group (1994), Randomized <code class="reqn">2\times2</code>
trial evaluating hormonal treatment and the duration of chemotherapy in
node-positive breast cancer patients.  <em>Journal of Clinical Oncology</em>,
<b>12</b>, 2086â€“2093.
</p>


</div>